Chris Pickford

Company: ADC Therapeutics

Job title: Head of Preclinical Research

Seminars:

Development & Application of Claudin 6-Targeted Therapies in Ovarian, Testicular, & Endometrial Cancers 2:15 pm

Focusing on Claudin 6 expression in ovarian, testicular, and endometrial cancers and the potential for targeted therapies in these indications Uncovering the development and clinical potential of ADCs targeting Claudin 6, including preclinical efficacy and safety data Highlighting the safety profile and patient selection criteria for Claudin 6-targeted therapies, including strategies to minimize off-target effectsRead more

day: Conference Day 1